A progressive stage IIIB melanoma treated with oncolytic ECHO-7 virus: A case report
Melanoma is an aggressive skin cancer form with a grave prognosis. Current results suggest that oncolytic virus treatment of melanoma has a high therapeutic potential. ECHO-7 (Rigvir) is the first…
Management of a primary malignant melanoma of uterine cervix stage IVA patient with radical surgery and adjuvant oncolytic virus Rigvir® therapy: A case report
A 25‐year‐old nulliparous woman was diagnosed with a primary malignant melanoma of the uterine cervix stage IVA. She has undergone surgery three times. The oncolytic virus Rigvir® was prescribed between the…
Rigvir holding concludes a deal with Chinese biotech company Sinorda Biomedicine on development and commercialisation of Oncolytic virotherapy cancer medicine in Chinese market
Rigvir holding concludes a deal with Chinese biotech company Sinorda Biomedicine on development and commercialisation of ECHO-7 oncolytic virotherapy cancer medicine in Chinese market and agrees on sales of minority…
